Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BDNFVal66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease
Yen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
Brain (2016) Vol. 139, Iss. 10, pp. 2766-2777
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain
Magdalena Miranda, Juan Facundo Morici, María Belén Zanoni, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 1095
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
Nicolas R. Barthélemy, Yan Li, Nelly Joseph‐Mathurin, et al.
Nature Medicine (2020) Vol. 26, Iss. 3, pp. 398-407
Open Access | Times Cited: 503
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
Li-Na Gao, Yun Zhang, Keenan Sterling, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 337
Effects of Neurotrophic Factors in Glial Cells in the Central Nervous System: Expression and Properties in Neurodegeneration and Injury
Suvi Pöyhönen, Şafak Er, Andrii Domanskyi, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 223
BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders
Ting Shen, Yuyi You, Chitra Joseph, et al.
Aging and Disease (2018) Vol. 9, Iss. 3, pp. 523-523
Open Access | Times Cited: 127
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease
Nicolai Franzmeier, Emrah Düzel, Frank Jessen, et al.
Brain (2018) Vol. 141, Iss. 4, pp. 1186-1200
Open Access | Times Cited: 99
Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Mabel Seto, Rebecca L. Weiner, Logan Dumitrescu, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 99
Impact of brain‐derived neurotrophic factor genetic polymorphism on cognition: A systematic review
Yi Long Toh, Terence Ng, Megan Tan, et al.
Brain and Behavior (2018) Vol. 8, Iss. 7
Open Access | Times Cited: 88
The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease
Nicolai Franzmeier, Jinyi Ren, Alexander Damm, et al.
Molecular Psychiatry (2019) Vol. 26, Iss. 2, pp. 614-628
Open Access | Times Cited: 80
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
Alexandre Bejanin, M. Florencia Iulita, Eduard Vilaplana, et al.
JAMA Neurology (2021) Vol. 78, Iss. 8, pp. 937-937
Open Access | Times Cited: 58
Translational approaches to understanding resilience to Alzheimer’s disease
Sarah M. Neuner, Maria A. Telpoukhovskaia, Vilas Menon, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 5, pp. 369-383
Open Access | Times Cited: 47
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ‐PET, neurodegeneration, and cognition
Pratishtha Chatterjee, Lisa Vermunt, Brian A. Gordon, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 7, pp. 2790-2804
Open Access | Times Cited: 44
Neurotrophin-targeted therapeutics: A gateway to cognition and more?
Gunnar Nordvall, Pontus Forsell, Johan Sandin
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103318-103318
Open Access | Times Cited: 37
Association ofBDNFVal66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease
Yen Ying Lim, Paul Maruff, Nicolas R. Barthélemy, et al.
JAMA Neurology (2022) Vol. 79, Iss. 3, pp. 261-261
Open Access | Times Cited: 30
The BDNF Val66Met Polymorphism Modulates Resilience of Neurological Functioning to Brain Ageing and Dementia: A Narrative Review
Donnamay Brown, James C. Vickers, Kimberley E. Stuart, et al.
Brain Sciences (2020) Vol. 10, Iss. 4, pp. 195-195
Open Access | Times Cited: 43
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer’s Disease
Lucia Caffino, Francesca Mottarlini, Fabio Fumagalli
CNS Drugs (2020) Vol. 34, Iss. 3, pp. 281-297
Open Access | Times Cited: 42
Alzheimer’s Disease, Neural Plasticity, and Functional Recovery
Daymara Mercerón‐Martínez, Cristobal Ibaceta‐Gonzalez, Claudia Salazar, et al.
Journal of Alzheimer s Disease (2021) Vol. 82, Iss. s1, pp. S37-S50
Closed Access | Times Cited: 34
Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network
Aurélie Bussy, B. Joy Snider, Dean W. Coble, et al.
Neurobiology of Aging (2018) Vol. 75, pp. 42-50
Open Access | Times Cited: 45
Medium- and high-intensity rTMS reduces psychomotor agitation with distinct neurobiologic mechanisms
Alesha Heath, Daniel R. Lindberg, Kalina Makowiecki, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease
Shudan Wang, Hongyang Yao, Yihua Xu, et al.
Theranostics (2020) Vol. 10, Iss. 15, pp. 6854-6874
Open Access | Times Cited: 39
Glial smog: Interplay between air pollution and astrocyte-microglia interactions
Mireia Gómez‐Budia, Henna Konttinen, Liudmila Saveleva, et al.
Neurochemistry International (2020) Vol. 136, pp. 104715-104715
Open Access | Times Cited: 38
Status of precision medicine approaches to traumatic brain injury
Anna O. Giarratana, Sahithi Reddi, Smita Thakker‐Varia, et al.
Neural Regeneration Research (2022) Vol. 17, Iss. 10, pp. 2166-2166
Open Access | Times Cited: 21
Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease
Alena Salašová, Giulia Monti, Olav M. Andersen, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 21
Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease
Andrea Kwakowsky, Michael Milne, Henry J. Waldvogel, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 12, pp. 2122-2122
Open Access | Times Cited: 34
Therapeutic potential of neurotrophic factors in Alzheimer’s Disease
Ava Nasrolahi, Fatemeh Javaherforooshzadeh, Mohsen Jafarzadehgharehziaaddin, et al.
Molecular Biology Reports (2021) Vol. 49, Iss. 3, pp. 2345-2357
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top